|
1
|
Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.
|
N Engl J Med
|
2009
|
1.63
|
|
2
|
Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes.
|
Eur Heart J
|
2010
|
1.14
|
|
3
|
Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease.
|
J Mol Med (Berl)
|
2010
|
1.13
|
|
4
|
Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment.
|
Mult Scler
|
2011
|
1.05
|
|
5
|
Exercise can rescue recognition memory impairment in a model with reduced adult hippocampal neurogenesis.
|
Front Behav Neurosci
|
2010
|
0.98
|
|
6
|
Effects of cytokines on microglial phenotypes and astroglial coupling in an inflammatory coculture model.
|
Glia
|
2005
|
0.95
|
|
7
|
Dexamethasone prevents LPS-induced microglial activation and astroglial impairment in an experimental bacterial meningitis co-culture model.
|
Brain Res
|
2010
|
0.94
|
|
8
|
Multiple sclerosis and pregnancy: experience from a nationwide database in Germany.
|
Ther Adv Neurol Disord
|
2012
|
0.93
|
|
9
|
Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab.
|
Mult Scler
|
2011
|
0.92
|
|
10
|
Allergic and nonallergic delayed infusion reactions during natalizumab therapy.
|
Arch Neurol
|
2008
|
0.90
|
|
11
|
Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis.
|
Mult Scler
|
2010
|
0.89
|
|
12
|
Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model.
|
Int J Neuropsychopharmacol
|
2007
|
0.88
|
|
13
|
Parenthood and immunomodulation in patients with multiple sclerosis.
|
J Neurol
|
2009
|
0.85
|
|
14
|
PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease.
|
Mol Neurodegener
|
2011
|
0.84
|
|
15
|
Protective effect of breastfeeding in postpartum relapse rate of mothers with multiple sclerosis.
|
Arch Neurol
|
2009
|
0.83
|
|
16
|
Dexamethasone differentially regulates functional membrane properties in glioma cell lines and primary astrocytes in vitro.
|
J Neurooncol
|
2010
|
0.82
|
|
17
|
Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation.
|
Br J Pharmacol
|
2011
|
0.82
|
|
18
|
Increased MS relapse rate during assisted reproduction technique.
|
J Neurol
|
2008
|
0.81
|
|
19
|
Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability.
|
Neurogenetics
|
2015
|
0.81
|
|
20
|
An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis.
|
J Neuroimmunol
|
2013
|
0.80
|
|
21
|
Managing MS in a changing treatment landscape.
|
J Neurol
|
2011
|
0.79
|
|
22
|
Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy.
|
Mult Scler
|
2012
|
0.77
|
|
23
|
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.
|
Immunity
|
2016
|
0.76
|
|
24
|
Sphingosine-1-phosphate and its receptors as a possible therapeutic target in autoimmune diseases of the nervous system.
|
J Neuroimmunol
|
2009
|
0.75
|
|
25
|
The agony of choice: diagnosis of cervical artery dissection by means of duplexsonography or magnetic resonance imaging?
|
Cerebrovasc Dis
|
2009
|
0.75
|
|
26
|
Wheels within wheels: multifocal autoimmune myelitis in a woman with Huntington's disease.
|
J Neurol
|
2012
|
0.75
|
|
27
|
Monitoring peripheral blood CD4(+) intracellular adenosine triphosphate concentration in patients with psoriasis treated with fumaric acid esters.
|
Acta Derm Venereol
|
2012
|
0.75
|
|
28
|
Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis.
|
Int Immunopharmacol
|
2012
|
0.75
|